IP Library Granted Patent US 8,290,564
Granted Patent B2
US 8,290,564 · App. 11/846,018 · Granted Oct 16, 2012

Method for bone structure prognosis and simulated bone remodeling

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,290,564
App. No.
11/846,018
Granted
Oct 16, 2012
Kind
B2
Abstract

Described herein are methods for analyzing bone structure and/or bone density, methods for estimating fracture risk in a subject as well as methods for monitoring the efficacy of an agent on bone structure and/or bone density.

Claims (48)

1. A method for analyzing bone structure or bone density using a computer system, the method comprising the steps of:

(a) obtaining two-dimensional image data of at least a portion of a subject's bone including trabecular bone, wherein said image data includes image data from at least two two-dimensional images of the subject's bone taken from at least two different angles;

(b) combining said at least two two-dimensional images into a volumetric image dataset;

(c) extracting a three-dimensional model representing the structure of trabecular bone from the volumetric image dataset;

(d) simulating bone remodeling using said three-dimensional model; and

(e) predicting structural strength of the bone based at least in part on the simulation of bone remodeling.

2. The method of claim 1 , wherein said at least two two-dimensional images of the subject's bone include x-ray images taken using at least two different x-ray beam rotation angles.

3. A method for monitoring the ability of an agent to affect bone quality, the method comprising the steps of:

(a) obtaining bone quality measurements on a subject by analyzing bone structure or bone density using the method according to claim 1 ;

(b) administering the agent to the subject;

(c) obtaining bone quality measurements of the subject after administration of the agent, wherein the bone quality measurements are obtained by analyzing bone structure or bone density using the method according to claim 1 ;

(d) comparing bone quality measurements from steps (a) and (c), wherein a difference in bone quality measurements between steps (a) and (c) is indicative of the ability of the agent to affect bone quality.

4. The method of claim 3 , wherein the bone quality measurements are bone density or bone structure measurements.

5. A method for analyzing bone structure or bone density using a computer system, the method comprising the steps of:

(a) obtaining image data from at least two two-dimensional images of at least a portion of a subject's bone including trabecular bone, the at least two two-dimensional images taken from at least two different angles;

(b) extracting a projection structure of trabecular bone from image data of each two-dimensional image of said at least two two-dimensional images;

(c) converting said projection structures into a three-dimensional probable model representing the volumetric structure of the trabecular bone;

(d) simulating bone remodeling using said model; and

(e) predicting structural strength of the bone based at least in part on the simulation of bone remodeling.

6. The method of claim 5 , wherein said at least two two-dimensional images of the subject's bone include x-ray images taken using at least two different x-ray beam rotation angles.

7. The method of claim 5 , further including performing a quantitative analysis of bone microarchitecture in each projection structure of trabecular bone before converting said projection structures into said three-dimensional probable model.

8. The method of claim 7 , wherein said converting said projection structures includes using said quantitative analysis of bone microarchitecture.

9. A method for monitoring the ability of an agent to affect bone quality, the method comprising the steps of:

(a) obtaining bone quality measurements on a subject by analyzing bone structure or bone density using the method according to claim 5 ;

(b) administering the agent to the subject;

(c) obtaining bone quality measurements of the subject after administration of the agent, wherein the bone quality measurements are obtained by analyzing bone structure or bone density using the method according to claim 5 ;

(d) comparing bone quality measurements from steps (a) and (c), wherein a difference in bone quality measurements between steps (a) and (c) is indicative of the ability of the agent to affect bone quality.

10. The method of claim 9 , wherein the bone quality measurements are bone density or bone structure measurements.

11. A method for estimating future fracture risk in a subject, the method comprising the steps of:

(a) obtaining two-dimensional image data of at least a portion of a subject's bone including trabecular bone, wherein said image data includes image data from at least two two-dimensional images of the subject's bone taken from at least two different angles;

(b) combining said at least two two-dimensional images into a volumetric image dataset;

(c) extracting a three-dimensional model representing the volumetric structure of trabecular bone from said volumetric image dataset;

(d) simulating bone remodeling using said model;

(e) predicting structural strength of the bone based at least in part on the simulation of bone remodeling; and

(f) comparing the predicted structural strength of the bone from the simulation of bone remodeling to measurements of population data, thereby predicting fracture risk in the subject.

12. The method of claim 11 , wherein the simulation of bone remodeling is of therapeutic interventions.

13. The method of claim 11 , wherein the simulation of bone remodeling is of disease progression.

14. The method of claim 11 , wherein one or more steps are automated.

15. A method for estimating future fracture risk in a subject, the method comprising the steps of:

(a) obtaining at least two two-dimensional images of at least a portion of a subject's bone including trabecular bone, the at least two two-dimensional images taken from at least two different angles;

(b) extracting a projection structure of the trabecular bone from each two-dimensional image of said at least two two-dimensional images;

(c) converting said projection structures into a three-dimensional probable model representing the volumetric structure of trabecular bone;

(d) simulating bone remodeling using said probable model;

(e) predicting structural strength of the bone based at least in part on the simulation of bone remodeling; and

(f) comparing the predicted structural strength of the bone from the simulation of bone remodeling to measurements of population data, thereby predicting fracture risk in the subject.

16. The method of claim 15 , wherein the simulation of bone remodeling is of therapeutic interventions.

17. The method of claim 15 , wherein the simulation of bone remodeling is of disease progression.

18. The method of claim 15 , wherein one or more steps are automated.

Assignments (9)
SECURITY INTEREST Recorded Jun 7, 2024
From: RESTOR3D, INC.; CONFORMIS, INC.; IMATX, INC.
To: TRINITY CAPITAL INC., AS ADMINISTRATIVE AGENT
Reel/Frame 067679/0713 →
RELEASE OF SECURITY INTEREST Recorded Sep 6, 2023
From: MIDCAP FINANCIAL TRUST, AS AGENT FOR LENDERS
To: CONFORMIS, INC.; IMATX, INC.
Reel/Frame 064818/0713 →
RELEASE OF SECURITY INTEREST Recorded Nov 23, 2021
From: CONFORMIS, INC.; IMATX, INC.; CONFORMIS CARES LLC
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 058234/0292 →
SECURITY INTEREST Recorded Nov 22, 2021
From: CONFORMIS, INC.; IMATX, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 058219/0346 →
RELEASE OF SECURITY INTEREST Recorded Jun 26, 2019
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: IMATX, INC.
Reel/Frame 049592/0351 →
SECURITY INTEREST Recorded Jun 25, 2019
From: CONFORMIS, INC.; IMATX, INC.; CONFORMIS CARES LLC
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 049588/0288 →
SECURITY INTEREST Recorded Jul 31, 2018
From: IMATX, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 046517/0636 →
MERGER AND CHANGE OF NAME Recorded Oct 19, 2011
From: IMAGING THERAPEUTICS, INC.
To: IMATX, INC.
Reel/Frame 027086/0217 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2008
From: LANG, PHILIPP; STEINES, DANIEL; ARNAUD, CLAUDE; LIEW, SIAU-WAY; VARGAS-VORACEK, RENE
To: IMAGING THERAPEUTICS, INC.
Reel/Frame 020901/0289 →